Reduce bounce rates Reduce bounce rates

Health & Lifestyle

GSK withdrew an application of a drug touted by Trump and RFK Jr. as a potential treatment for autism. The drug’s label last month was updated so that generic versions of it can be marketed for a rare genetic, neurological condition, but not autism.

InfoVera Team April 9, 2026 1 minute read

GSK withdrew an application of a drug touted by Trump and RFK Jr. as a potential treatment for autism. The drug’s label last month was updated so that generic versions of it can be marketed for a rare genetic, neurological condition, but not autism.

Generic versions of the drug will still be available to treat a rare genetic condition.

InfoVera Team

Administrator

Visit Website View All Posts

Related

Discover more from InfoVera USA

Subscribe to get the latest posts sent to your email.

Leave a ReplyCancel reply

Reduce bounce rates